Cargando…
Congenital muscular dystrophy caused by beta1,3-N-acetylgalactosaminyltransferase 2 gene mutation: Two case reports
BACKGROUND: Mutations in the beta1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2) gene can lead to impaired glycosylation of α-dystroglycan, which, in turn, causes congenital muscular dystrophy (CMD). The clinical phenotypes of CMD are broad, and there are only a few reports of CMD worldwide. CASE...
Autores principales: | Wu, Wen-Juan, Sun, Su-Zhen, Li, Bao-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790464/ https://www.ncbi.nlm.nih.gov/pubmed/35127920 http://dx.doi.org/10.12998/wjcc.v10.i3.1056 |
Ejemplares similares
-
N-acetylgalactosaminyltransferases in cancer
por: Hussain, Muhammad Ramzan Manwar, et al.
Publicado: (2016) -
Polypeptide N-acetylgalactosaminyltransferase-Associated Phenotypes in Mammals
por: Kato, Kentaro, et al.
Publicado: (2021) -
Two closely spaced mutations in cis result in Ullrich congenital muscular dystrophy
por: Shimomura, Hideki, et al.
Publicado: (2019) -
Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
por: Guo, Yan, et al.
Publicado: (2017) -
ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies
por: Cirak, Sebahattin, et al.
Publicado: (2013)